Telix Pharmaceuticals Limited vs ADMA Biologics, Inc.: Examining Key Revenue Metrics

Biotech Revenue Surge: Telix vs. ADMA from 2014 to 2023

__timestamp	ADMA Biologics, Inc.	Telix Pharmaceuticals Limited
Wednesday, January 1, 2014	5915545	28336824
Thursday, January 1, 2015	7177633	32319194
Friday, January 1, 2016	10661037	29404631
Sunday, January 1, 2017	22760560	31769230
Monday, January 1, 2018	16985290	20439380
Tuesday, January 1, 2019	29349083	24186536
Wednesday, January 1, 2020	42219783	4680000
Friday, January 1, 2021	80942625	4898000
Saturday, January 1, 2022	154079692	155984000
Sunday, January 1, 2023	258214999	496659000

Unlocking the unknown

A Tale of Two Biotechs: Revenue Growth from 2014 to 2023

In the dynamic world of biotechnology, Telix Pharmaceuticals Limited and ADMA Biologics, Inc. have showcased remarkable revenue trajectories over the past decade. From 2014 to 2023, Telix Pharmaceuticals experienced a staggering growth, culminating in a 1,650% increase in revenue by 2023. Meanwhile, ADMA Biologics also demonstrated impressive growth, with a 4,260% rise in revenue during the same period.

Key Insights

Telix Pharmaceuticals: Starting with a modest revenue in 2014, Telix's revenue surged to nearly $500 million by 2023, highlighting its strategic advancements in the biotech sector.
ADMA Biologics: With a consistent upward trend, ADMA's revenue reached approximately $258 million in 2023, reflecting its robust market presence.

This comparison underscores the potential and resilience of biotech companies in navigating market challenges and capitalizing on growth opportunities.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

Johnson & Johnson or Telix Pharmaceuticals Limited: Who Leads in Yearly Revenue?

Breaking Down Revenue Trends: GSK plc vs ADMA Biologics, Inc.

BeiGene, Ltd. vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared

Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.: Annual Revenue Growth Compared

Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis

Revenue Insights: Telix Pharmaceuticals Limited and Merus N.V. Performance Compared

Telix Pharmaceuticals Limited and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis

Breaking Down Revenue Trends: Telix Pharmaceuticals Limited vs Supernus Pharmaceuticals, Inc.

Annual Revenue Comparison: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.

Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Perrigo Company plc

Comparing Revenue Performance: ADMA Biologics, Inc. or Geron Corporation?

ADMA Biologics, Inc. and Galapagos NV: A Comprehensive Revenue Analysis